82 FR 19085 - Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 78 (April 25, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 78 (April 25, 2017)
| Page Range | 19085-19086 | |
| FR Document | 2017-08344 |
[Federal Register Volume 82, Number 78 (Tuesday, April 25, 2017)] [Notices] [Pages 19085-19086] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-08344] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 26, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on December 19, 2016, Sigma Aldrich Research Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760-2447 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Cathinone........................... 1235 I Methcathinone....................... 1237 I Mephedrone (4-Methyl-N- 1248 I methylcathinone). Aminorex............................ 1585 I Alpha-ethyltryptamine............... 7249 I Lysergic acid diethylamide.......... 7315 I Tetrahydrocannabinols............... 7370 I 4-Bromo-2,5-dimethoxyamphetamine.... 7391 I 4-Bromo-2,5-dimethoxyphenethylamine. 7392 I 4-Methyl-2,5-dimethoxyamphetamine... 7395 I 2,5-Dimethoxyamphetamine............ 7396 I 3,4-Methylenedioxyamphetamine....... 7400 I N-Hydroxy-3,4- 7402 I methylenedioxyamphetamine. 3,4-Methylenedioxy-N- 7404 I ethylamphetamine. 3,4-Methylenedioxymethamphetamine... 7405 I Dimethyltryptamine.................. 7435 I Psilocybin.......................... 7437 I 5-Methoxy-N,N-diisopropyltryptamine. 7439 I 1-[1-(2- 7470 I Thienyl)cyclohexyl]piperidine. N-Benzylpiperazine.................. 7493 I MDPV (3,4- 7535 I Methylenedioxypyrovalerone). Methylone (3,4-Methylenedioxy-N- 7540 I methylcathinone). Heroin.............................. 9200 I Normorphine......................... 9313 I Norlevorphanol...................... 9634 I Amphetamine......................... 1100 II Methamphetamine..................... 1105 II Nabilone............................ 7379 II 1-Phenylcyclohexylamine............. 7460 II Phencyclidine....................... 7471 II Cocaine............................. 9041 II Codeine............................. 9050 II Ecgonine............................ 9180 II [[Page 19086]] Levomethorphan...................... 9210 II Levorphanol......................... 9220 II Meperidine.......................... 9230 II Metazocine.......................... 9240 II Methadone........................... 9250 II Morphine............................ 9300 II Thebaine............................ 9333 II Levo-alphacetylmethadol............. 9648 II Remifentanil........................ 9739 II Sufentanil.......................... 9740 II Carfentanil......................... 9743 II Fentanyl............................ 9801 II ------------------------------------------------------------------------ The company plans to manufacture reference standards. Dated: April 18, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017-08344 Filed 4-24-17; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices 19085
Controlled substance Drug code Schedule
Codeine .......................................................................................................................................................................... 9050 II
Oxycodone ..................................................................................................................................................................... 9143 II
Hydromorphone ............................................................................................................................................................. 9150 II
Hydrocodone .................................................................................................................................................................. 9193 II
Methadone ..................................................................................................................................................................... 9250 II
Methadone intermediate ................................................................................................................................................ 9254 II
Dextropropoxyphene, bulk (non-dosage forms) ............................................................................................................ 9273 II
Morphine ........................................................................................................................................................................ 9300 II
Oripavine ........................................................................................................................................................................ 9330 II
Thebaine ........................................................................................................................................................................ 9333 II
Opium tincture ............................................................................................................................................................... 9630 II
Oxymorphone ................................................................................................................................................................ 9652 II
The company plans to manufacturer DATES: Registered bulk manufacturers of respect to the promulgation and
the listed controlled substances in bulk the affected basic classes, and implementation of 21 CFR part 1301,
for distribution to its customers. applicants therefore, may file written incident to the registration of
Dated: April 18, 2017. comments on or objections to the manufacturers, distributors, dispensers,
Louis J. Milione,
issuance of the proposed registration in importers, and exporters of controlled
accordance with 21 CFR 1301.33(a) on substances (other than final orders in
Assistant Administrator.
or before June 26, 2017. connection with suspension, denial, or
[FR Doc. 2017–08347 Filed 4–24–17; 8:45 am]
ADDRESSES: Written comments should revocation of registration) has been
BILLING CODE 4410–09–P redelegated to the Assistant
be sent to: Drug Enforcement
Administration, Attention: DEA Federal Administrator of the DEA Diversion
Register Representative/DRW, 8701 Control Division (‘‘Assistant
DEPARTMENT OF JUSTICE
Morrissette Drive, Springfield, Virginia Administrator’’) pursuant to section 7 of
Drug Enforcement Administration 22152. 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
[Docket No. DEA–392] SUPPLEMENTARY INFORMATION: The 1301.33(a), this is notice that on
Attorney General has delegated his December 19, 2016, Sigma Aldrich
Bulk Manufacturer of Controlled authority under the Controlled Research Biochemicals, Inc., 1–3
Substances Application: Sigma Aldrich Substances Act to the Administrator of Strathmore Road, Natick, Massachusetts
Research Biochemicals, Inc. the Drug Enforcement Administration 01760–2447 applied to be registered as
(DEA), 28 CFR 0.100(b). Authority to a bulk manufacturer of the following
ACTION: Notice of application.
exercise all necessary functions with basic classes of controlled substances:
Controlled substance Drug code Schedule
Cathinone ....................................................................................................................................................................... 1235 I
Methcathinone ............................................................................................................................................................... 1237 I
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................. 1248 I
Aminorex ........................................................................................................................................................................ 1585 I
Alpha-ethyltryptamine .................................................................................................................................................... 7249 I
Lysergic acid diethylamide ............................................................................................................................................ 7315 I
Tetrahydrocannabinols .................................................................................................................................................. 7370 I
4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................ 7391 I
4-Bromo-2,5-dimethoxyphenethylamine ........................................................................................................................ 7392 I
4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................ 7395 I
2,5-Dimethoxyamphetamine .......................................................................................................................................... 7396 I
3,4-Methylenedioxyamphetamine .................................................................................................................................. 7400 I
N-Hydroxy-3,4-methylenedioxyamphetamine ................................................................................................................ 7402 I
3,4-Methylenedioxy-N-ethylamphetamine ..................................................................................................................... 7404 I
3,4-Methylenedioxymethamphetamine .......................................................................................................................... 7405 I
Dimethyltryptamine ........................................................................................................................................................ 7435 I
Psilocybin ....................................................................................................................................................................... 7437 I
5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................ 7439 I
1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................. 7470 I
N-Benzylpiperazine ........................................................................................................................................................ 7493 I
MDPV (3,4-Methylenedioxypyrovalerone) ..................................................................................................................... 7535 I
Methylone (3,4-Methylenedioxy-N-methylcathinone) .................................................................................................... 7540 I
Heroin ............................................................................................................................................................................ 9200 I
Normorphine .................................................................................................................................................................. 9313 I
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Norlevorphanol ............................................................................................................................................................... 9634 I
Amphetamine ................................................................................................................................................................. 1100 II
Methamphetamine ......................................................................................................................................................... 1105 II
Nabilone ......................................................................................................................................................................... 7379 II
1-Phenylcyclohexylamine .............................................................................................................................................. 7460 II
Phencyclidine ................................................................................................................................................................. 7471 II
Cocaine .......................................................................................................................................................................... 9041 II
Codeine .......................................................................................................................................................................... 9050 II
Ecgonine ........................................................................................................................................................................ 9180 II
VerDate Sep<11>2014 17:42 Apr 24, 2017 Jkt 241001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\25APN1.SGM 25APN1](https://thefederalregister.org/doc/82_FR_19163/page/1.svg)
![19086 Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices
Controlled substance Drug code Schedule
Levomethorphan ............................................................................................................................................................ 9210 II
Levorphanol ................................................................................................................................................................... 9220 II
Meperidine ..................................................................................................................................................................... 9230 II
Metazocine ..................................................................................................................................................................... 9240 II
Methadone ..................................................................................................................................................................... 9250 II
Morphine ........................................................................................................................................................................ 9300 II
Thebaine ........................................................................................................................................................................ 9333 II
Levo-alphacetylmethadol ............................................................................................................................................... 9648 II
Remifentanil ................................................................................................................................................................... 9739 II
Sufentanil ....................................................................................................................................................................... 9740 II
Carfentanil ...................................................................................................................................................................... 9743 II
Fentanyl ......................................................................................................................................................................... 9801 II
The company plans to manufacture address one or more of the following probation offices for which a central
reference standards. four points: reporting authority does not exist. For
Dated: April 18, 2017. —Evaluate whether the proposed the CJ–7 form, the affected public
Louis J. Milione, collection of information is necessary consists of 53 respondents including 51
for the proper performance of the central reporters (two state respondents
Assistant Administrator.
functions of the Bureau of Justice in Pennsylvania, and one each from the
[FR Doc. 2017–08344 Filed 4–24–17; 8:45 am]
Statistics, including whether the remaining states), the District of
BILLING CODE 4410–09–P Columbia, and the Federal Bureau of
information will have practical utility;
—Evaluate the accuracy of the agency’s Prisons responsible for keeping records
estimate of the burden of the on parolees. For the CJ–8 form, the
DEPARTMENT OF JUSTICE proposed collection of information, affected public includes 305 reporters
[OMB Number 1121–0064] including the validity of the including 35 state respondents, the
methodology and assumptions used; District of Columbia, the Federal Bureau
Agency Information Collection —Evaluate whether and if so how the of Prisons, and 268 from local
Activities; Proposed eCollection quality, utility, and clarity of the authorities responsible for keeping
eComments Requested; Extension of a information to be collected can be records on probationers. For the CJ–8A
Currently Approved Collection: Annual enhanced; and form, the affected public includes 151
Parole Survey, Annual Probation —Minimize the burden of the collection reporters who are all local authorities
Survey of information on those who are to responsible for keeping records on
respond, including through the use of probationers. The Annual Parole Survey
AGENCY: Bureau of Justice Statistics, appropriate automated, electronic, and Annual Probation surveys have
Department of Justice. mechanical, or other technological been used since 1977 to collect annual
ACTION: 60-Day notice. collection techniques or other forms yearend counts and yearly movements
of information technology, e.g., of community corrections populations;
SUMMARY: The Department of Justice permitting electronic submission of characteristics of the community
(DOJ), Office of Justice Programs, responses. supervision population, such as gender,
Bureau of Justice Statistics, will be
Overview of This Information racial composition, ethnicity, conviction
submitting the following information
Collection status, offense, and supervision status.
collection request to the Office of
Management and Budget (OMB) for 1. Type of Information Collection: 5. An estimate of the total number of
review and approval in accordance with Extension of a currently approved respondents and the amount of time
the Paperwork Reduction Act of 1995. collection. estimated for an average respondent to
2. The Title of the Form/Collection: respond: 509 respondents each taking
DATES: Comments are encouraged and
Annual Parole Survey, Annual an average of 1.63 hours to respond.
will be accepted for 60 days until June
26, 2017. Probation Survey. 6. An estimate of the total public
3. The agency form number, if any, burden (in hours) associated with the
FOR FURTHER INFORMATION CONTACT: If
and the applicable component of the collection: There is an estimated 830
you have additional comments Department sponsoring the collection: total burden hours associated with this
especially on the estimated public Form numbers for the questionnaire are collection.
burden or associated response time, CJ–7 Annual Parole Survey; CJ–8
suggestions, or need a copy of the If additional information is required
Annual Probation Survey; CJ–8a Annual contact: Melody Braswell, Department
proposed information collection Probation Survey (Short Form). The
instrument with instructions or Clearance Officer, United States
applicable component within the Department of Justice, Justice
additional information, please contact Department of Justice is the Bureau of
Danielle Kaeble, Statistician, Bureau of Management Division, Policy and
Justice Statistics, in the Office of Justice Planning Staff, Two Constitution
Justice Statistics, 810 Seventh Street
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Programs. Square, 145 N Street NE., 3E.405A,
NW., Washington, DC 20531 (email: 4. Affected public who will be asked
Danielle.Kaeble@usdoj.gov; telephone: Washington, DC 20530.
or required to respond, as well as a brief
202–305–2017). Dated: April 20, 2017.
abstract:
SUPPLEMENTARY INFORMATION: Written Primary: State departments of Melody Braswell,
comments and suggestions from the corrections or state probation and parole Department Clearance Officer for PRA, U.S.
public and affected agencies concerning authorities. Department of Justice.
the proposed collection of information Others: The Federal Bureau of [FR Doc. 2017–08342 Filed 4–24–17; 8:45 am]
are encouraged. Your comments should Prisons, city and county courts and BILLING CODE 4410–18–P
VerDate Sep<11>2014 17:42 Apr 24, 2017 Jkt 241001 PO 00000 Frm 00071 Fmt 4703 Sfmt 9990 E:\FR\FM\25APN1.SGM 25APN1](https://thefederalregister.org/doc/82_FR_19163/page/2.svg)
Document Created: 2017-04-25 02:18:13
Document Modified: 2017-04-25 02:18:13
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 26, 2017. | |
| FR Citation | 82 FR 19085 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR